BeStock  
Stocks › Biotechnology › PVLA

Palvella Therapeutics PVLA

US equityMarket cap rank #2653Biotechnology
$142.85 −$2.92 (-2.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $142.85 0.00%
Open$143.10
Prev close$145.77
Day range$142.22 – $148.69
Volume192.7K
Market cap$2.09B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts12
Average target$227.73+59.4% vs. price
  • Buy 100%
Low $207.00Now $142.85Avg $227.73High $246.00

Recent rating changes

The last 20 actions on file set price targets from $207.00 to $266.00, averaging $232.78.

DateFirmRatingTarget
9 Nov 2026 CCORF BUY $243.00
6 Nov 2026 Craig-Hallum BUY $230.00
6 Nov 2026 Raymond James BUY $230.00
6 Nov 2026 Truist Financial BUY $207.00
6 Nov 2026 H.C. Wainwright BUY $246.00
6 Nov 2026 Oppenheimer BUY $232.00
5 Nov 2026 BTIG BUY $215.00
29 Oct 2026 Mizuho Securities BUY $232.00
28 Oct 2026 William Blair BUY –
21 Oct 2026 Cantor Fitzgerald BUY $210.00
20 Oct 2026 Clear Street BUY $220.00
20 Oct 2026 H.C. Wainwright BUY $246.00
16 Oct 2026 Raymond James BUY –
15 Oct 2026 William Blair BUY $266.00
12 Oct 2026 BTIG BUY $215.00
12 Oct 2026 H.C. Wainwright BUY $246.00
21 Sep 2026 Chardan Capital BUY $240.00
10 Sep 2026 Mizuho Securities BUY $240.00
31 Aug 2026 Mizuho Securities BUY $240.00
5 Aug 2026 CCORF BUY $232.00

Discussion

No comments yet — be the first to weigh in on PVLA.

Sign in to join the discussion.

Scroll to Top